Qualifying Conditions Of Medical Cannabis License Holders In The United States
Qualifying Conditions Of Medical Cannabis License Holders In The United States
复制标题
DOI：
10.1377/hlthaff.2018.05266
复制
发表时间：
2019-02-01
期刊：
影响因子：
9.7
通讯作者：
Haffajee, Rebecca L.
中科院分区：
文献类型：
--
作者：
Boehnke, Kevin F.;Gangopadhyay, Saurav;Haffajee, Rebecca L.
大麻在不同条件下的治疗效果的证据差异很大，并且缺乏关于人们使用大麻的条件的全面数据。我们分析了州登记数据，以提供全国范围内的估计，这些估计描述了患者被许可在医学上使用大麻的合格条件。我们还将医用大麻合格条件的流行率与美国国家科学院、工程院和医学院最近关于大麻治疗每种疾病的疗效报告的证据进行了比较。20个州和哥伦比亚特区有关于患者数量的可用登记数据，15个州有关于患者报告的合格条件的数据。慢性疼痛是目前和历史上医用大麻患者报告的最常见的合格条件（2016年为64.9%）。在所有患者报告的合格条件中，85.5%有实质性或决定性的治疗有效性证据。随着医用大麻的使用继续增加，建立一个全国性的患者登记册将有助于更好地了解使用趋势及其潜在的有效性。
The evidence for cannabis's treatment efficacy across different conditions varies widely, and comprehensive data on the conditions for which people use cannabis are lacking. We analyzed state registry data to provide nationwide estimates characterizing the qualifying conditions for which patients are licensed to use cannabis medically. We also compared the prevalence of medical cannabis qualifying conditions to recent evidence from the National Academies of Sciences, Engineering, and Medicine report on cannabis's efficacy in treating each condition. Twenty states and the District of Columbia had available registry data on patient numbers, and fifteen states had data on patient-reported qualifying conditions. Chronic pain is currently and historically the most common qualifying condition reported by medical cannabis patients (64.9 percent in 2016). Of all patient-reported qualifying conditions, 85.5 percent had either substantial or conclusive evidence of therapeutic efficacy. As medical cannabis use continues to increase, creating a nationwide patient registry would facilitate better understanding of trends in use and of its potential effectiveness.